• CRISPR Therapeutics' (CRSP) Market Outperform Rating Reiterated at JMP Securities

    Source: Buzz FX / 13 Feb 2025 09:36:10   America/Chicago


    CRISPR Therapeutics' (CRSP) Market Outperform Rating Reiterated at JMP Securities Written by MarketBeat February 13, 2025 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) 's stock had its "market outperf
    Read more...
Share on,